Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.270
+0.040 (3.25%)
May 19, 2026, 4:00 PM EDT - Market closed

Entera Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
639082212181
Market Cap Growth
-39.90%8.81%286.81%1.21%-74.11%257.16%
Enterprise Value
58.8382.7473.7810.528.7281.23
Last Close Price
1.271.942.120.600.732.82
PE Ratio
-7.768.481.941.626.00
PS Ratio
-2133.01454.89-156.95-
PB Ratio
5.546.8410.192.051.79-
P/TBV Ratio
5.616.849.881.681.79-
EV/Sales Ratio
-1969.97407.61-65.09-
Debt / Equity Ratio
0.020.020.010.020-
Net Debt / Equity Ratio
-0.34-0.50-1.04-1.02-1.04-
Net Debt / EBITDA Ratio
0.300.580.881.200.94-
Net Debt / FCF Ratio
0.400.891.231.450.97-
Asset Turnover
-0.000.0200.02-
Quick Ratio
2.633.237.4710.109.36-
Current Ratio
7.936.947.6310.329.58-
Return on Equity (ROE)
-106.21%-108.01%-103.34%-80.30%-222.41%-
Return on Assets (ROA)
-85.88%-90.84%-90.75%-71.67%-200.42%-
Return on Invested Capital (ROIC)
-172.33%-347.47%3942.13%2774.53%6090.22%-
Return on Capital Employed (ROCE)
-98.69%-104.79%-101.49%-79.17%-220.89%-
Earnings Yield
-12.89%11.79%51.67%61.64%16.67%
Buyback Yield / Dilution
-20.29%-22.68%-29.79%-0.69%-10.23%-19.13%
Total Shareholder Return
-20.29%-22.68%-29.79%-0.69%-10.23%-19.13%
Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q